2012-2013 Executive Committee pictured.
Sitting from left to right: Daniel Hays, Lea Eiland, Erin Fox
Standing from left to right: Michelle Allen, Tricia Meyer, James Trovato (ASHP Board Liaison), Jill Bates, and Angela Raval
Chair (2012-13)
Lea S. Eiland, Pharm.D., BCPS, FASHP
Huntsville, AL
Lea S. Eiland is an Associate Clinical Professor and Associate Department Head of Pharmacy Practice, Auburn University Harrison School of Pharmacy; a Clinical Associate Professor of Pediatrics, University of Alabama at Birmingham School of Medicine, Huntsville Regional Medical Campus; and pediatric pharmacist, Huntsville Hospital. She received her Pharm.D. from The University of Texas and completed an ASHP-accredited pediatric specialty residency at Texas Tech University.
Eiland has been an active member of ASHP serving the SCSS as a Director-at-Large for the Executive Committee and a Network Facilitator. She has served on the EVP/CEO Search and Screen Committee; Chair of the Council on Education and Workforce Development; Task Force on Pharmacy’s Changing Demographics; and state delegate. She has published in AJHP and serves as a reviewer. Eiland is the Past-President of AlSHP, faculty advisor for Auburn student chapter and has received the AlSHP Pharmacist of the Year Award.
Lea S. Eiland can be e-mailed at sections@ashp.org.
Chair-Elect (2012-2013)
Jill S. Bates, MS, PharmD, BCOP
Chapel Hill, NC
Jill S. Bates, MS, PharmD, BCOP, is a Clinical Pharmacy Specialist in Hematology/Oncology within the University of North Carolina (UNC) Healthcare System; a Clinical Assistant Professor at the UNC Eshelman School of Pharmacy in Chapel Hill, North Carolina. She received her Doctor of Pharmacy degree at the University of Illinois at Chicago and her Master of Science in Biochemistry and Biophysics from Northern Illinois University. Jill completed an ASHP-accredited pharmacy practice (PGY1) and oncology (PGY2) residency at Duke University Medical Center.
Jill has been an active member of ASHP serving on the Council on Therapeutics as Vice Chair and Chair. She has also served on the New Practitioner Education Advisory Group and as a member of the Educational Steering Committee for the section. Jill holds leadership positions on the UNC credentialing committee and chemotherapy policy advisory group and fosters professional service as a manuscript reviewer.
Jill S. Bates can be e-mailed at sections@ashp.org.
Immediate Past Chair (2012-2013)
Erin R. Fox, Pharm.D., FASHP
Salt Lake City, Utah
Erin R. Fox, Pharm.D. is Manager of the Drug Information Service at University of Utah Health Care and Associate Professor (Adjunct), at the Department of Pharmacotherapy, University of Utah College of Pharmacy. Fox received her Pharm.D. from the University of Utah and completed a specialized residency in Drug Information at the University of Utah Hospitals & Clinics. Fox directs the activities of the Drug Information Service which provides content for the American Society of Health-System Pharmacists (ASHP) Drug Shortage Resource Center. Fox has led the drug shortages project since 2001. Fox is honored to have served the ASHP Section of Clinical Specialists and Scientists in a variety of roles including Director-At-Large for the executive committee, Chair and Vice-Chair of the Section’s Programming Committee, and Network Facilitator for Drug Information and Pharmacoeconomics. Fox is also active in the Utah affiliate of ASHP serving in elected and appointed positions.
Erin R. Fox can be e-mailed at sections@ashp.org.
Director-at-Large (2012-14)
Michelle E. Allen, Pharm.D., BCPS, FCCM
Santa Rosa, CA
Michelle E. Allen, PharmD, BCPS, FCCM, is exceedingly honored to have joined ASHP’s Section of Clinical Specialists and Scientists Executive Committee as the Director-at-Large in June 2012. She brings to the committee a variety of clinical, academic and administrative experiences: Inpatient Pharmacy Supervisor for a Northern California Kaiser Foundation Hospital; Clinical Coordinator and PGY1 Residency Director for Johns Hopkins Medicine’s Sibley Memorial Hospital in Washington, District of Columbia; Critical Care Clinical Specialist and PGY2 Residency Director for Shands at the University of Florida in Gainsville, Florida; and Associate Clinical Professor for University of Florida’s College of Pharmacy. Michelle is currently employed by St. Joseph Health System in Santa Rosa, CA, and West County’s Palm Drive Hospital in Sebastopol, CA. She received her Bachelor’s of Science degree from the University of California at Berkeley, and her Doctor of Pharmacy degree from the University of Pittsburgh. PGY1-2 residency training was completed at the University Medical Center at the University of Arizona in Tucson, AZ.
Michelle is active professionally in both pharmacy and critical care, having served as a Chair for ASHP’s New Practitioners Forum, Treasurer and member of the Board of Directors for the Washington-Metropolitan Society of Health-System Pharmacists, and Chair of the Society of Critical Care Medicine’s (SCCM) Education and Training Steering Committee, and SCCM’s Accreditation and On-Line Learning Committee.
Michelle E. Allen can be e-mailed at sections@ashp.org.
Director-at-Large (2011-2013)
Tricia Meyer, M.S., Pharm.D., FASHP
Temple, TX
Tricia Meyer, M.S., Pharm.D., FASHP is Director of Pharmacy, Scott & White Healthcare and Assistant Professor of Anesthesiology, Texas A&M Health Science Center College of Medicine and Adjunct Assistant Professor for the College of Pharmacy. She earned her B.S. in Pharmacy from the University of Texas, M.S. from Texas State University and Pharm.D. from Shenandoah University. Her duties range from pharmacy administration to perioperative clinical pharmacy services. Meyer has conducted numerous clinical research trials and Q.I. projects. Meyer serves on the Anesthesia Patient Safety Foundation and co-chair’s the SAMBA Guidelines for Prevention & Treatment of Post-operative Nausea and Vomiting.
Active in ASHP, has served on the Advisory Group for Investigational Drugs and panel for Sustained Contributions to the Literature. Meyer has served on TSHP Board of Directors, Council on Educational Affairs and held local offices. Meyer has published and presented nationally and received the ASHP Best Practice Award.
Tricia Meyer can be e-mailed at sections@ashp.org.
Director-at-Large-Elect (2012-2013)
Daniel P. Hays, Pharm.D., BCPS, FASHP
Tucson, AZ
Daniel P. Hays is an internationally recognized leader in the field of Emergency Pharmacy. He has implemented two highly successful Emergency Pharmacy programs as well as two successful PGY-2 training programs for cultivating future Emergency Pharmacists. After graduating from the University of Minnesota, he built his practice in Rochester, NY where he was the lead pharmacist on an AHRQ grant to study the effect of a pharmacist on patient care in the Emergency Department. Dr. Hays is currently on the faculty at the University of Arizona schools of Medicine and Pharmacy. He has served on the Educational Steering Committee of ASHP’s Clinical Scientists and Specialists and as previous chair for the Section Advisory Group of Emergency Care. Dr. Hays has also contributed to two ASHP Best Practice Awards. Dr. Hays has written numerous chapters for text books in both pharmacy and emergency medicine practice related to the dynamics of Emergency Pharmacy.
Daniel P. Hays can be e-mailed at sections@ashp.org.
ASHP Staff
Angela R. Raval, Pharm.D.
Director, Section of Clinical Specialists and Scientists
Angela R. Raval is the Director for the Section of Clinical Specialists and Scientists. In this role Angela serves as an information resource and provides guidance to ASHP members regarding science and scientific developments affecting pharmacy practice in health systems. She also serves as secretary to the Section executive committee and coordinates activities to accomplish the objectives established by the Section.
Angela received her Bachelor degree in Microbiology and Cell Science from the University of Florida and Doctor of Pharmacy from the University of Illinois at Chicago. She also completed an ASHP accredited residency in pharmacy practice at the Washington Hospital Center in Washington, DC. Prior to her current position at ASHP, Angela practiced as a clinical pharmacist at Children’s National Medical Center in Washington, DC. She also held the position of Safety Evaluator at the Food and Drug Administration where she monitored medication adverse event reports and was a Drug Information Analyst at ASHP writing and updating drug monographs for the AHFS Drug Information publication.
Past Executive Committees